In recent years, we have seen antimicrobial resistance rapidly emerge at a global scale and
spread from one country to the other faster than previously thought. Superbugs and …

The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important
role in this variability. The commensal microbiota living in the human gut encodes several …

Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) are the most common
types of infections in women. The antibiotic resistance of E. coli is increasing rapidly …

Urinary tract infections (UTIs) are among the most common bacterial infections, especially
among women and older adults, leading to a significant global healthcare cost burden …

Drug resistance in tuberculosis (TB) is a particular problem because the lengthy therapy of
at least 6 months makes patient compliance very difficult, which frequently creates drug …

Most nitroaromatic compounds are toxic and mutagenic for living organisms, but some
microorganisms have developed oxidative or reductive pathways to degrade or transform …

Nitroaromatic compounds are xenobiotics that have found multiple applications in the
synthesis of foams, pharmaceuticals, pesticides, and explosives. These compounds are …

The prodrug nifurtimox has been used for more than 40 years to treat Chagas disease and
forms part of a recently approved combinational therapy that targets West African …

Although Escherichia coli has long been recognized as the best-understood living organism,
little was known about its abilities to use aromatic compounds as sole carbon and energy …

Summary Chromate [Cr (VI)] is a serious environmental pollutant, which is amenable to
bacterial bioremediation. NfsA, the major oxygen‐insensitive nitroreductase of Escherichia …